Moleculin Graham Number from 2010 to 2024

MBRX Stock  USD 2.62  0.03  1.13%   
Moleculin Biotech Graham Number yearly trend continues to be fairly stable with very little volatility. Graham Number will likely drop to 63.55 in 2024. During the period from 2010 to 2024, Moleculin Biotech Graham Number regression line of annual values had r-squared of  0.01 and arithmetic mean of  116.36. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
66.89103079
Current Value
63.55
Quarterly Volatility
92.67009967
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Moleculin Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Moleculin Biotech's main balance sheet or income statement drivers, such as Interest Income of 965.1 K, Depreciation And Amortization of 120.7 K or Interest Expense of 2.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.02. Moleculin financial statements analysis is a perfect complement when working with Moleculin Biotech Valuation or Volatility modules.
  
Check out the analysis of Moleculin Biotech Correlation against competitors.
For more information on how to buy Moleculin Stock please use our How to Invest in Moleculin Biotech guide.

Latest Moleculin Biotech's Graham Number Growth Pattern

Below is the plot of the Graham Number of Moleculin Biotech over the last few years. It is Moleculin Biotech's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Moleculin Biotech's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Very volatile
   Graham Number   
       Timeline  

Moleculin Graham Number Regression Statistics

Arithmetic Mean116.36
Geometric Mean92.93
Coefficient Of Variation79.64
Mean Deviation70.91
Median66.89
Standard Deviation92.67
Sample Variance8,588
Range277
R-Value0.11
Mean Square Error9,144
R-Squared0.01
Significance0.71
Slope2.20
Total Sum of Squares120,228

Moleculin Graham Number History

2024 63.55
2023 66.89
2022 94.08
2021 70.04
2020 117.94
2019 150.33
2018 214.56

About Moleculin Biotech Financial Statements

Moleculin Biotech investors use historical fundamental indicators, such as Moleculin Biotech's Graham Number, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Moleculin Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Graham Number 66.89  63.55 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Moleculin Stock Analysis

When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.